Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors
Xiaoliu Zhang(University of Yamanashi), K Sugita(University of Yamanashi), Toshiya Inaba(Hiroshima University), Hidemitsu Kurosawa(St. Jude Children's Research Hospital), Itaru Kuroda(University of Yamanashi), Takeshi Inukai(University of Yamanashi), Masao Kobayashi(Higashi Osaka City General Hospital), Makoto Endo(Kyushu University), S Nakazawa(Saitama Children's Medical Center), Hideo Yagita∥(Juntendo University), Koshi Akahane(University of Yamanashi), Hiroko Honna-Oshiro(University of Yamanashi), A. Thomas Look(Dana-Farber Cancer Institute), H. Honda(Nagaoka University), K Hirose(University of Yamanashi), Kumiko Goi(St. Jude Children's Research Hospital), K Kagami(University of Yamanashi), Kazuhiro Nakamura(Nagoya University)
Cited by 17
Related Papers
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
|Cancer Cell|2002|1.1k
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
|Nature Immunology|2012|832
<i>FBW7</i> mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
|The Journal of Experimental Medicine|2007|660
Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish
|Journal of Leukocyte Biology|2006|527